arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

Solventum Corp

SOLV
$82.98 ▼ -0.08 (-0.10%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
15 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
64
Health
Fair
Bullish
auto_awesome

Analytical Summary

Solventum Corp shows strong fundamentals with top-quartile Return on Common Equity (%) and Profit Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $14.5B
Dividend Yield
Revenue Growth -3.0%
Op. Margin 4.0%
ROIC 0.7%
FCF / Share $-1.57
Trailing P/E 1185.4x
Price / Book 2.9x
FCF Yield
Debt / Equity 0.92
info Valuation on last close. End-of-day price, Aug 7, 2026.

15-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$2.01B
↓ -3.0%
Net Income Profit after all expenses
$13.00M
↓ -90.5%
Operating Margin Operating profit as % of sales
4.0%
↓ -35.0% 83th
FCF / Share Free cash flow per share
$-1.57
↓ -240.3%
Long-Term Debt Long-term obligations
$4.58B
↓ -9.1%
trending_up

Bullish Indicators

  • Operating Margin (%)Operating Margin (%) is in the top quartile
  • Profit Margin (%)Profit Margin (%) is in the top quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
62
Returns
93
Financial Health
51
Cash Quality
22

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 5 years · 15 quarters